[ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].
D035843:Biomedical Research; D001921:Brain; D002395:Catecholamines; D004295:Dihydroxyphenylalanine; D007980:Levodopa; D008660:Metabolism; D010300:Parkinson Disease; D020734:Parkinsonian Disorders; D010600:Pharmacology; D012110:Reserpine; D014116:Toxicology
D002395:Catecholamines; D007980:Levodopa; D004295:Dihydroxyphenylalanine; D012110:Reserpine
BRAIN; CATECHOLAMINES; CLINICAL RESEARCH; DOPA; METABOLISM; PARKINSONISM; PHARMACOLOGY; RESERPINE; TOXICOLOGIC REPORT
WEITERE EXPERIMENTELLE UNTERSUCHUNGEN UEBER L-DOPA BEIM PARKINSON-SYNDROM UND RESERPIN-PARKINSONISMUS.